Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?

about

Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?

Item

http://www.wikidata.org/entity/Q42687197

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Does antiretroviral treatment ...... sitive pulmonary tuberculosis?

@en

Does antiretroviral treatment ...... sitive pulmonary tuberculosis?

@nl

type

Item

label

Does antiretroviral treatment ...... sitive pulmonary tuberculosis?

@en

Does antiretroviral treatment ...... sitive pulmonary tuberculosis?

@nl

prefLabel

Does antiretroviral treatment ...... sitive pulmonary tuberculosis?

@en

Does antiretroviral treatment ...... sitive pulmonary tuberculosis?

@nl

P1476

Does antiretroviral treatment ...... sitive pulmonary tuberculosis?

@en

P2093

J R Glynn

http://www.w3.org/2001/XMLSchema#string

K Kranzer

http://www.w3.org/2001/XMLSchema#string

K L Fielding

http://www.w3.org/2001/XMLSchema#string

O Koole

http://www.w3.org/2001/XMLSchema#string

P Y Khan

http://www.w3.org/2001/XMLSchema#string

T Mzembe

http://www.w3.org/2001/XMLSchema#string

P2860

Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural Malawi

Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Antiretroviral therapy for tuberculosis control in nine African countries.

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.

Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients.

Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005-2012.

Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.

The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study

Can we control tuberculosis in high HIV prevalence settings?

What has Karonga taught us? Tuberculosis studied over three decades.

P304

1147-1154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5588/IJTLD.17.0162

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amelia Crampin

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29037295

http://www.w3.org/2001/XMLSchema#string

P932

5644739

http://www.w3.org/2001/XMLSchema#string